Tablets and capsules: what binders and fillers actually do
Bulk, binding, disintegration and flow are formulation jobs—not automatic signs of poor quality. Uniform distribution and tested performance matter more than “filler-free” language.
- Evidence type
- Formulation principles + FDA/USP quality standards
- Provenance
- Adapted from RUO
- Status
- Published 1 November 2026
Adapted with permission from the owner’s reviewed RUO source material. Members-only references are linked below; public research citations support the scientific context.
The active ingredient is not the whole formulation
An active ingredient may occupy only a small fraction of a solid dosage form. The remaining materials can have practical jobs: providing enough bulk to manufacture consistently, holding a tablet together, helping it break apart, or improving powder flow. The reviewed RUO excerpt explains those roles rather than treating every non-active ingredient as unnecessary dilution.
A filler or diluent supplies bulk. A binder helps particles cohere. A disintegrant helps the dosage form break up after contact with fluid. Flow aids and lubricants support handling and manufacturing. “Inactive” describes their therapeutic role; it does not mean they have no effect on how a formulation behaves.
Small amounts make distribution important
When the active mass is tiny, simply seeing powder in a capsule says little about how evenly the active ingredient is distributed. Mixing, segregation and manufacturing consistency can influence whether individual units contain the intended amount. Tablets and capsules both need appropriate control of that variation.
Content uniformity therefore answers a different question from ingredient-list length: how consistent is the active content from unit to unit? FDA guidance addresses uniformity testing for tablets and capsules, while USP standards address excipient identity, purity and quality. Neither topic can be settled by the presence or absence of the word “filler.”
Judge the function and the evidence
A capsule is not automatically additive-free, and a tablet is not automatically inferior because it needs binding or disintegration support. Materials must be suitable for the intended formulation; individual sensitivities and compatibility also matter. A useful quality assessment considers identity, content, uniformity, stability and relevant release performance rather than assuming one format wins by default.
This is formulation literacy, not a recommendation to purchase or prepare a product. The potential benefit is a better reading of quality claims: identify what each ingredient is meant to do, then look for evidence that the finished formulation performs consistently. The members-only RUO post supplies the reviewed educational angle, with public FDA and USP references alongside it.
Keywordsexcipients · tablets · capsules · binders · fillers · disintegration · lubricants · content uniformity
Public research & references
Research education, not individualized medical advice.